Breast Cancer Explained: Types, Symptoms, Screening, Diagnosis and Treatment
Breast cancer is a disease in which abnormal cells in breast tissue grow in an uncontrolled way. These cells may begin in milk ducts or milk-producing lobules and can remain in the breast or spread to nearby lymph nodes and other parts of the body. Understanding breast cancer types, symptoms, screening, diagnosis and treatment helps explain how the disease is identified and managed.
What breast cancer means
Breast cancer is not one single disease. It includes several forms that differ according to where abnormal cells begin, whether they invade nearby tissue, and whether they have biological features that affect treatment. Ductal and lobular cancers are two major groups, while less common forms include Paget disease and inflammatory breast cancer.
Some breast-cell changes are noninvasive. Ductal carcinoma in situ, or DCIS, describes abnormal cells contained within a milk duct. Lobular carcinoma in situ, or LCIS, is different: it is not considered breast cancer but is associated with a higher future risk.
Breast cancer can affect women and, less commonly, men. Risk generally increases with age, although younger people can also develop it. Family history, inherited gene changes, previous radiation exposure, reproductive factors, alcohol use, tobacco use, excess body weight and some hormone-related factors can influence risk. However, many people diagnosed with breast cancer have no known major risk factor apart from age and sex.
Main types
Breast cancer types are also described by biomarkers. Tests can determine whether cancer cells have receptors for estrogen or progesterone and whether they have increased levels of the HER2 protein. These findings can help classify the cancer and guide treatment planning.
| Type or feature | General meaning |
|---|---|
| Ductal carcinoma | Begins in cells lining milk ducts; it may be noninvasive or invasive |
| Lobular carcinoma | Begins in milk-producing lobules; it may be noninvasive or invasive |
| DCIS | Abnormal duct cells that have not invaded surrounding breast tissue |
| Triple-negative | Lacks estrogen, progesterone and HER2 receptors |
| HER2-positive | Has increased HER2 protein or related gene activity |
| Hormone-receptor positive | Has estrogen and/or progesterone receptors |
Importance
Why symptoms matter
Breast changes do not automatically mean cancer. Lumps, cysts, infections and other conditions can produce similar findings. Even so, a new or persistent change deserves appropriate medical assessment rather than being judged by appearance alone.
Possible breast cancer symptoms include:
- A new lump or thickened area in the breast or underarm
- A change in breast size or shape
- Skin dimpling, puckering, redness or thickening
- A nipple that turns inward when this is a new change
- Nipple discharge, particularly when it is unusual or bloody
- A persistent change around the nipple or areola
- Swelling or changes involving nearby lymph nodes
Some breast cancers cause no noticeable symptoms, which is why screening can have a role for people in appropriate age or risk groups. Screening and diagnosis are different: screening looks for possible disease before symptoms appear, while diagnostic testing investigates a symptom or an abnormal screening result.
Who may be affected
Breast cancer occurs worldwide and becomes more common with increasing age. WHO reports about 2.4 million women were diagnosed globally in 2024 and notes that most breast cancers occur without a specific risk factor other than sex and age.
Early diagnosis depends on recognizing concerning changes and completing appropriate evaluation. Screening methods and age recommendations vary according to health systems and individual risk.
Recent Updates
Changes in detection and diagnosis
Recent guidance continues to emphasize earlier detection, timely diagnosis and coordinated care. Diagnosis commonly combines clinical assessment, imaging and tissue testing rather than relying on a single test.
Mammography remains a standard screening method for many women. Ultrasound and breast MRI can be used in selected situations or for some higher-risk groups. A biopsy examines tissue under a microscope and is the definitive method for confirming breast cancer.
More detailed cancer classification
Breast cancer treatment planning increasingly depends on both the visible stage of disease and biological characteristics. Pathology can report tumor type, grade and biomarkers such as estrogen receptor, progesterone receptor and HER2 status. Genetic testing may also be considered for selected people based on personal or family history and other clinical factors.
Recent treatment guidance also reflects more individualized combinations of local and whole-body approaches. Surgery and radiation therapy are used for local control, while systemic approaches may be used when cancer cells need to be addressed beyond the original breast area. Depending on cancer type and stage, treatment may involve hormone-based treatment, chemotherapy, targeted treatment or immunotherapy.
Research is also examining imaging, biomarker testing, genetic information and treatment sequencing to match treatment decisions more closely with the characteristics of each cancer.
Laws or Policies
India’s public-health framework
In India, breast cancer screening and early detection are included within the national approach to non-communicable diseases. The National Programme for Prevention and Control of Non-Communicable Diseases includes population-based screening for common cancers, including breast, cervical and oral cancers. The programme targets people aged 30 years and above for screening of common non-communicable diseases through public-health facilities.
The screening pathway can involve frontline health workers, primary health facilities, community health centres and district hospitals, with referral to higher-level facilities when further assessment is needed. Government health programmes also support cancer-care infrastructure and referral pathways across states and union territories.
What screening policy means for individuals
A national screening programme does not mean that every person should have the same test at the same interval. Screening decisions can depend on age, symptoms, personal risk, family history and the health system in the area. A person with a new breast symptom is generally evaluated as a diagnostic case rather than simply waiting for a routine screening appointment.
India's public-health materials also describe clinical breast examination as part of population-based screening and recommend further assessment when an examination identifies a concerning finding. Current national training materials describe imaging and biopsy as parts of the diagnostic pathway when breast cancer is suspected.
Tools and Resources
Screening and diagnosis resources
Educational resources can help readers understand breast cancer without replacing clinical assessment. Useful categories include:
- Mammography information: Explains breast X-ray screening and possible screening results.
- Breast ultrasound information: Describes sound-wave imaging of breast tissue and abnormalities.
- Breast MRI information: Explains its use for selected assessments or higher-risk groups.
- Pathology reports: Provide cancer type, grade and biomarker information.
- Family-history tools: Help organize relevant family cancer history and risk factors.
- National health portals: Provide information about screening programmes and referral pathways.
The National Cancer Institute and World Health Organization provide educational material on breast cancer screening, diagnosis, treatment and research. Indian government health portals publish information about population-based screening and non-communicable-disease programmes.
Understanding the diagnosis pathway
A typical pathway may include a clinical breast examination, imaging and biopsy when indicated. Additional tests can determine whether cancer has spread and identify biological features that influence treatment planning.
Staging describes the extent of cancer in the body, including tumor size, lymph-node involvement and possible distant spread. Stage and biomarker results are considered together when treatment is planned.
FAQs
What are the common breast cancer symptoms?
Common breast cancer symptoms can include a new breast or underarm lump, skin dimpling or thickening, a change in breast shape, nipple changes or unusual nipple discharge. Some cancers have no noticeable symptoms, so screening may detect abnormalities before symptoms develop.
How does breast cancer screening work?
Breast cancer screening checks people who do not have symptoms for signs that may need further evaluation. Mammography is a standard screening test for many women, while other imaging methods may be used for selected situations or risk groups. Screening recommendations vary by age, risk and national health guidance.
What happens during breast cancer diagnosis?
Diagnosis may involve a clinical examination, mammography, ultrasound or MRI, followed by a biopsy when an abnormal area requires tissue testing. A pathologist examines the tissue and may report the cancer type, grade and biomarkers. These results help determine stage and treatment planning.
What are the main breast cancer treatment options?
Treatment can include surgery, radiation therapy and systemic treatment. Depending on the type and stage, systemic approaches may include hormone-based treatment, chemotherapy, targeted treatment or immunotherapy. Many treatment plans use more than one approach.
Can men develop breast cancer?
Yes. Breast cancer can occur in men, although it is much less common than in women. A persistent lump, nipple change or other unusual breast change can require medical evaluation.
Conclusion
Breast cancer includes several diseases with different tissue origins, stages and biological features. Common areas of breast cancer evaluation include symptoms, screening, imaging, biopsy, pathology and staging. Treatment planning depends on the cancer type, biomarkers, stage and individual clinical circumstances. Public-health programmes in India include population-based screening and referral pathways as part of broader non-communicable-disease control.
